💊 Abbott India – Swing Trade Idea
Ticker: NSE: ABBOTINDIA
Timeframe: 1D
Bias: Bullish Rebound
📊 Technical Setup
Price has corrected into a strong demand zone (₹30,000–30,500) supported by long-term rising channel.
Forming a descending triangle breakout setup with confluence of support.
RSI near 40, showing oversold-to-reversal potential.
Volume contraction → suggests accumulation phase before breakout.
📌 Trade Plan
Entry: ₹31,000–31,200 (on sustained close above short-term trendline).
Target 1: ₹34,500
Target 2: ₹37,000+
Stoploss: ₹30,000 (below demand zone).
Risk:Reward ≈ 1:3
🔮 Astro Justification
Sun governs health, vitality, and pharmaceuticals. Its current strengthening in transit supports momentum in the pharma sector.
Jupiter’s aspect is bringing institutional inflows toward defensive stocks like pharma & FMCG, especially in uncertain market phases.
Historically, pharma counters respond positively during Sun + Jupiter supportive cycles, aligning with Abbott India’s potential rebound.
⚠️ Disclaimer
This is for educational purposes only, not financial advice. Do your own analysis and manage risk before trading.
Ticker: NSE: ABBOTINDIA
Timeframe: 1D
Bias: Bullish Rebound
📊 Technical Setup
Price has corrected into a strong demand zone (₹30,000–30,500) supported by long-term rising channel.
Forming a descending triangle breakout setup with confluence of support.
RSI near 40, showing oversold-to-reversal potential.
Volume contraction → suggests accumulation phase before breakout.
📌 Trade Plan
Entry: ₹31,000–31,200 (on sustained close above short-term trendline).
Target 1: ₹34,500
Target 2: ₹37,000+
Stoploss: ₹30,000 (below demand zone).
Risk:Reward ≈ 1:3
🔮 Astro Justification
Sun governs health, vitality, and pharmaceuticals. Its current strengthening in transit supports momentum in the pharma sector.
Jupiter’s aspect is bringing institutional inflows toward defensive stocks like pharma & FMCG, especially in uncertain market phases.
Historically, pharma counters respond positively during Sun + Jupiter supportive cycles, aligning with Abbott India’s potential rebound.
⚠️ Disclaimer
This is for educational purposes only, not financial advice. Do your own analysis and manage risk before trading.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.